Clinical Trials for Metastatic Prostate Small Cell Neuroendocrine Carcinoma

Find clinical trials for metastatic prostate small cell neuroendocrine carcinoma. Discover research opportunities and treatment options in your area.

2 Active Trials Found

Showing 2 trials on this page

Page 1 of 1

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

NCT ID: NCT03866382

This clinical trial is investigating how well three medications—cabozantinib, nivolumab, and ipilimumab—work together to treat patients with rare genitourinary tumors that have spread to other part...

Recruiting

Phase: PHASE2 Type: interventional Locations: Chicago, Illinois, United States, Brooklyn, New York, United States +640 more

Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

NCT ID: NCT05691465

This clinical trial is investigating a new treatment called Lutetium Lu 177 dotatate for men with metastatic prostate cancer that has neuroendocrine differentiation, meaning the cancer cells have c...

Recruiting

Phase: PHASE2 Type: interventional Locations: Chicago, Illinois, United States, Duarte, California, United States +13 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions